Chandigarh, January 1, 2026 – Nectar Lifesciences Limited (NECLIFE) recorded a muted response on the first day of its ongoing share buyback, with the offer subscribed 0.16 times as of 4:00 p.m. on December 31, 2025, largely driven by participation from individual investors.
The company is conducting a fixed-price buyback of up to 3 crore equity shares at ₹27 per share, with the offer window open from December 31, 2025 to January 6, 2026.
Buyback SnapshotParticularsDetailsCompanyNectar Lifesciences LimitedSymbolNECLIFESeriesBBOffer TypeBuybackIssue TypeFixed PriceOffer Price₹27 per equity shareFace Value₹1Issue SizeUp to 3,00,00,000 equity sharesOffer PeriodDecember 31, 2025 – January 6, 2026Market Lot1...